Literature DB >> 21256052

The aortic valve microenvironment and its role in calcific aortic valve disease.

Cindy Ying Yin Yip1, Craig A Simmons.   

Abstract

In calcific aortic valve disease, fibrotic and calcific lesions form focally in the fibrosa layer of the valve leaflets. Layer-specific pathosusceptibility suggests that the fibrosa microenvironment is permissive to pathological development. The cellular microenvironment in the aortic valve is defined by a variety of biomechanical-, biochemical-, and extracellular-mediated factors, some of which are unique to the fibrosa. Growing evidence supports the role of these microenvironmental cues in the local regulation of side-specific valve cell phenotypes and focal pathological alterations, revealing new insights into the cellular and molecular processes that contribute to calcific aortic valve disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256052     DOI: 10.1016/j.carpath.2010.12.001

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  37 in total

1.  Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent.

Authors:  Charles I Fisher; Joseph Chen; W David Merryman
Journal:  Biomech Model Mechanobiol       Date:  2012-02-04

2.  SPATIO-TEMPORAL COMPLEXITY OF THE AORTIC SINUS VORTEX.

Authors:  Brandon Moore; Lakshmi Prasad Dasi
Journal:  Exp Fluids       Date:  2014-06-01       Impact factor: 2.480

3.  A time course investigation of the statin paradox among valvular interstitial cell phenotypes.

Authors:  Elyssa L Monzack; Kristyn S Masters
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 4.  Molecular and cellular aspects of calcific aortic valve disease.

Authors:  Dwight A Towler
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

5.  Inflammation is associated with the remodeling of calcific aortic valve disease.

Authors:  Nancy Coté; Ablajan Mahmut; Yohan Bosse; Christian Couture; Sylvain Pagé; Sylvain Trahan; Marie-Chloé Boulanger; Dominique Fournier; Philippe Pibarot; Patrick Mathieu
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

6.  Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Authors:  Emanuela Branchetti; Rachana Sainger; Paolo Poggio; Juan B Grau; Jeffrey Patterson-Fortin; Joseph E Bavaria; Michael Chorny; Eric Lai; Robert C Gorman; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

7.  The role of valvular endothelial cell paracrine signaling and matrix elasticity on valvular interstitial cell activation.

Authors:  Sarah T Gould; Emily E Matherly; Jennifer N Smith; Donald D Heistad; Kristi S Anseth
Journal:  Biomaterials       Date:  2014-01-24       Impact factor: 12.479

Review 8.  Shear-Sensitive Genes in Aortic Valve Endothelium.

Authors:  Joan Fernández Esmerats; Jack Heath; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2016-01-21       Impact factor: 8.401

Review 9.  Fibrous scaffolds for building hearts and heart parts.

Authors:  A K Capulli; L A MacQueen; Sean P Sheehy; K K Parker
Journal:  Adv Drug Deliv Rev       Date:  2015-12-04       Impact factor: 15.470

10.  Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Authors:  Paolo Poggio; Rachana Sainger; Emanuela Branchetti; Juan B Grau; Eric K Lai; Robert C Gorman; Michael S Sacks; Alessandro Parolari; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-03-12       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.